Research and regulatory reference
ARA-290
A source-linked reference on the identity and evidence context of ARA-290. Sources checked 6 September 2026.
Source and review status
Published sources checked
Sources checked on: 6 September 2026
Qualified clinical review: Pending. This page has not been clinically reviewed.
About this source check
AI-assisted editorial source checking covers the cited material and its stated limits. It is not a systematic review, verification of a supplied product, or clinical sign-off.
Editorial role: InfoAddict. Last material change: 6 September 2026. Next source review: 6 December 2026.
Identity
ARA-290 is also called cibinetide and is an erythropoietin-derived peptide.
Sources: Published 2015
A named substance and a finished product are different claims. The name does not verify formulation, concentration, purity or equivalence to material used in a study.
Research context
This was a defined phase-II population and limited observation period. It cannot establish effectiveness for other conditions or products.
Sources: Published 2015
The source is informative only for its stated population and research question. It should not be read as an assessment of a different product, a broader health outcome or an individual person’s circumstances.
Evidence boundary
This entry reports the limited source context above. It does not make a personal treatment recommendation or infer a result from a different molecule, formulation, model or study population.
The appropriate conclusion is limited to the cited record, not to untested products or uses.
Published sources
- ARA 290, a nonerythropoietic peptide engineered from erythropoietin, improves metabolic control and neuropathic symptoms in patients with type 2 diabetes
Published 2015. Current article record; accessed 6 September 2026.
Supports: A phase-II study in people with type-2 diabetes.
Change history
| Date | Change | Clinical-review status |
|---|---|---|
| 6 September 2026 | Source-linked reference published | Pending |
Keep a private record
UpgradeYourself lets you keep private records of routines and observations you choose to discuss with a qualified health professional. This reference does not recommend starting, stopping or changing an item.